
Name: Bernie Tuch
Position: Director
Email: afdr@optusnet.com.au
Website: http://afdr.org.au
PO Box 821
Maroubra NSW 2035
Our Mission / Objective
The Australian Foundation for Diabetes Research:
(a) supports the development of a therapy that will allow the growing number of insulin-dependent Australians to cease having to inject insulin multiple times each day of their lives;
(b) helps educate the wider community about the development of therapies to overcome the need for insulin for many young people with diabetes
Our Services
Provide seed funding to assist diabetes research both within the laboratory and the clinic
- Assist in the development of a cell therapy for type 1 diabetes
- Give access to human embryonic stem cell lines
- Help in purchase of research equipment
- Facilitate teaching of stem cell usage
- Train researchers in bioengineering and other techniques
- Support employment of Post-doctoral fellows
- Provide travel funds to support the further training of researchers and visiting Research Fellows
- Provide scholarship to PhD students
Our Beneficiaries
- Diabetes Transplant Unit, Prince of Wales Hospital & University of New South Wales. 2002-9
- Diabetes Research Unit, Western Australian Institute for Medical Research, University of Western Australia. 2009-11
- Commonwealth Scientific Industrial Research Organization. 2010-4
- The University of Sydney. 2015 – 2019
- The University of Technology Sydney. 2020-
- Queensland University of Technology. 2020-
Projects in Progress
At University of Technology Sydney
-
Studies in diabetic mice that are implanted with human insulin-producing cells seeded in a bioengineered device to determine if blood sugar levels can be normalized. Chief investigator- A/Prof. Hui Chen. This is a prelude to a clinical trial using such cells in a device that overcomes the need for giving patients anti-rejection drugs.
-
Use of nanoparticles to cause local regulated release of immunomodulatory molecules, which may be of assistance in enhancing cell therapies for diabetes. Supported by the Juvenile Diabetes Research Foundation. Chief investigator- Dr. Helen Xu.
Our People
CEO
Names of Board Members
Professor Bernard Tuch
Mr Steven Nemes
Professor Geoffrey Symonds
Dr John Gallo
Registration Information
ABN
Tax Deductible
How to help us
Wills and Bequests
This is handled by Director of the Foundation, Mr Steven Nemes, of Harris Freidman Lawyers – snemes@hflawyers.com.au
General Donations
These are tax deductible
Work with us
Volunteer with us
Our Annual Reports
Our Mission / Objective
The Australian Foundation for Diabetes Research:
(a) supports the development of a therapy that will allow the growing number of insulin-dependent Australians to cease having to inject insulin multiple times each day of their lives;
(b) helps educate the wider community about the development of therapies to overcome the need for insulin for many young people with diabetes
Our Services
Provide seed funding to assist diabetes research both within the laboratory and the clinic
- Assist in the development of a cell therapy for type 1 diabetes
- Give access to human embryonic stem cell lines
- Help in purchase of research equipment
- Facilitate teaching of stem cell usage
- Train researchers in bioengineering and other techniques
- Support employment of Post-doctoral fellows
- Provide travel funds to support the further training of researchers and visiting Research Fellows
- Provide scholarship to PhD students
Our Beneficiaries
- Diabetes Transplant Unit, Prince of Wales Hospital & University of New South Wales. 2002-9
- Diabetes Research Unit, Western Australian Institute for Medical Research, University of Western Australia. 2009-11
- Commonwealth Scientific Industrial Research Organization. 2010-4
- The University of Sydney. 2015 – 2019
- The University of Technology Sydney. 2020-
- Queensland University of Technology. 2020-
Projects in Progress
At University of Technology Sydney
-
Studies in diabetic mice that are implanted with human insulin-producing cells seeded in a bioengineered device to determine if blood sugar levels can be normalized. Chief investigator- A/Prof. Hui Chen. This is a prelude to a clinical trial using such cells in a device that overcomes the need for giving patients anti-rejection drugs.
-
Use of nanoparticles to cause local regulated release of immunomodulatory molecules, which may be of assistance in enhancing cell therapies for diabetes. Supported by the Juvenile Diabetes Research Foundation. Chief investigator- Dr. Helen Xu.
Our People
CEO
Names of Board Members
Professor Bernard Tuch
Mr Steven Nemes
Professor Geoffrey Symonds
Dr John Gallo
Registration Information
ABN
Tax Deductible
How to Help us
Wills and Bequests
This is handled by Director of the Foundation, Mr Steven Nemes, of Harris Freidman Lawyers – snemes@hflawyers.com.au
General Donations
These are tax deductible